Patents by Inventor Jorge L. Munoz-Jordan

Jorge L. Munoz-Jordan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10563269
    Abstract: Processes for detecting Dengue virus (DENV) nucleic acid in a sample are provided including producing an amplification product by amplifying DENV nucleotide sequence and detection of an amplification by hybridization of a probe or other technique. The processes use primers or probes with introduced mutations and or degenerate bases that provide excellent superiority in detection and serotyping of DENV in a sample.
    Type: Grant
    Filed: April 17, 2017
    Date of Patent: February 18, 2020
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Jorge L. Munoz-Jordan, Edgardo Vergne, Gilberto Santiago
  • Publication number: 20170275711
    Abstract: Processes for detecting Dengue virus (DENV) nucleic acid in a sample are provided including producing an amplification product by amplifying DENV nucleotide sequence and detection of an amplification by hybridization of a probe or other technique. The processes use primers or probes with introduced mutations and or degenerate bases that provide excellent superiority in detection and serotyping of DENV in a sample.
    Type: Application
    Filed: April 17, 2017
    Publication date: September 28, 2017
    Applicant: The U.S.A., as represented by the Secretary, Department of Health and Human Services
    Inventors: Jorge L. Munoz-Jordan, Edgardo Vergne, Gilberto Santiago
  • Patent number: 9657361
    Abstract: Processes for detecting Dengue virus (DENV) nucleic acid in a sample are provided including producing an amplification product by amplifying DENV nucleotide sequence and detection of an amplification by hybridization of a probe or other technique. The processes use primers or probes with introduced mutations and or degenerate bases that provide excellent superiority in detection and serotyping of DENV in a sample.
    Type: Grant
    Filed: October 25, 2012
    Date of Patent: May 23, 2017
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Jorge L. Munoz-Jordan, Edgardo Vergne, Gilberto Santiago
  • Publication number: 20140315745
    Abstract: Processes for detecting Dengue virus (DENV) nucleic acid in a sample are provided including producing an amplification product by amplifying DENV nucleotide sequence and detection of an amplification by hybridization of a probe or other technique. The processes use primers or probes with introduced mutations and or degenerate bases that provide excellent superiority in detection and serotyping of DENV in a sample.
    Type: Application
    Filed: October 25, 2012
    Publication date: October 23, 2014
    Inventors: Jorge L. Munoz-Jordan, Edgardo Vergne, Gilberto Santiago